Levomepromazin Terapia (Levomepromazine Maleate)

Levomepromazine works by blocking dopamine D2 receptors, which reduces dopaminergic activity linked to psychosis. It also antagonises histamine H1, muscarinic, and alpha‑adrenergic receptors, providing sedative, anti‑emetic, and anticholinergic effects while influencing blood pressure and cardiovascular tone.

The specific dose of Levomepromazin Terapia is determined by the prescribing clinician based on the patient’s condition, severity, age, and response to therapy. Dosage may be titrated gradually, and the prescriber will select an appropriate regimen that balances efficacy with safety.

Safety data for levomepromazine in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant. Clinicians typically evaluate each case individually and consider alternative therapies when possible.

To order Levomepromazin Terapia, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Levomepromazine belongs to the phenothiazine class, which is a typical antipsychotic with strong dopamine antagonism and additional antihistamine, anticholinergic and alpha‑blocking properties. Compared with atypical antipsychotics, it may cause more sedation and anticholinergic effects but can be useful for severe agitation and nausea where other agents are less effective.

Levomepromazin Terapia should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid exposing it to extreme temperatures or humidity.

Levomepromazin is administered orally. The tablets or capsules should be swallowed whole with a glass of water, preferably with food or a light snack to reduce gastrointestinal irritation. The exact route and timing are directed by the prescribing healthcare professional.

The most serious risks include neuroleptic malignant syndrome, a potentially life‑threatening reaction characterized by fever, muscle rigidity and autonomic instability; tardive dyskinesia, which may cause irreversible involuntary movements; severe hypotension or cardiac arrhythmias; and rare blood disorders such as agranulocytosis.

Levomepromazin should be avoided in individuals with known hypersensitivity to phenothiazines, those with severe cardiovascular disease prone to orthostatic hypotension, patients with a history of neuroleptic malignant syndrome, and anyone taking medications that could cause dangerous additive effects without close monitoring.